Navigation Links
Reproductive health: Checkerboard of infertility treatment in Europe
Date:10/6/2010

Bad Hofgastein, 6 October 2010 -- European patients are in many countries, in fact, limited in their individual choice of medically assisted reproduction (MAR) treatment, experts from the European Society of Human Reproduction and Embryology (ESHRE) stressed today at the European Health Forum Gastein (EHFG).

The EHFG is the most important conference on health care policy in the EU. This year it has attracted about 600 decision-makers from more than 40 countries in the fields of health care policy, research, science, and business as well as from patients' organizations.

During an ESHRE workshop the political, professional, industrial and patient perspectives highlighted the problems related to the patchwork of MAR regulation in Europe. The regulatory diversity in MAR is attributed to the religious, cultural, social, ethical and moral attitudes prevalent in individual countries towards human life and its origins. In particular, gamete and embryo donation, surrogacy and preimplantation genetic diagnosis are hot spots in MAR regulation in Europe.

Demand for infertility treatment on the rise The field of MAR is subject to the EU directive 2004/23/EC on quality and safety of human tissues and cells. "19 Member States have specific legislations in place for MAR, in the remaining eight countries, MAR is covered by the general health legislation," said Isabel de la Mata from the European Commission. "The organization of health systems is the exclusive competence of the members, meaning the legally allowed forms of treatment, the eligibility criteria and the reimbursement of treatments all vary between the Member States." And yet demand for MAR treatment is on the rise in Europe. The latest survey by ESHRE - the only one of its kind in Europe found that 494,599 treatment cycles were performed in Europe in 2006 compared to 203,893 cycles ten years earlier. The number of clinics reporting to the survey increased from 482 to 1,016 during the same period. In several European countries 2-5% of children are born after MAR, with every one in six couples seeking some sort of medical assistance in order to achieve a pregnancy. 30,000 couples seek treatment outside their home countries

"Due to the inequality of reimbursement and treatment unavailability, many patients seek treatment outside their home country, often putting themselves and their unborn babies at risk," explained Clare Lewis Jones, Chair of Fertility Europe, the umbrella organization of patient associations in Europe. Cross border travel for reproductive care is becoming a relevant phenomenon in Europe. A recent study by ESHRE showed that an estimated 11,000 to 14,000 patients go abroad for treatment each year in the six European countries studied (Belgium, Czech Republic, Denmark, Switzerland, Spain and Slovenia). "We estimate that about 30,000 couples cross borders each year in Europe to receive assisted reproduction treatment," said Luca Gianaroli, chairman of ESHRE.

"Less restrictive reimbursement policies leading to increased accessibility and use of MAR would be incentives for the industry to increase development efforts in this area," said Joan-Carles Arce, Vice President of R&D at Ferring Pharmaceuticals. "In addition, funding of academia-industry collaborations would stimulate further research within MAR and facilitate that new treatment concepts are being developed and subsequently put into clinical practice. It would also have a beneficial impact on the drug development activities if pricing and reimbursement authorities rewarded innovation."

"ESHRE is concerned about the heterogeneity that still exists in Europe," explained Luca Gianaroli. "At the European level a serious and fundamental reflection of MAR legislation is necessary to ensure that treatments of proven benefit to patients and offspring are made available in Europe, irrespective of the patient's income, marital status and place of residence." ESHRE believes this discussion should take place together with professionals in the fields and patients.


'/>"/>

Contact: Hanna Hanssen
hanna@eshre.eu
32-473-353-381
European Society of Human Reproduction and Embryology
Source:Eurekalert

Related biology news :

1. UNH researcher helps identify key reproductive hormone in oldest vertebrate
2. Nobel Prize for Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online
3. Caltech and UCSD scientists establish leech as model for study of reproductive behavior
4. Studies examine how living conditions impact reproductive health
5. New developments in reproductive medicine
6. 2 reproductive factors are important predictors of death from ovarian cancer
7. Plastics chemical retards growth, function of adult reproductive cells
8. Environmental cues control reproductive timing and longevity, University of Minnesota study shows
9. Stress puts double whammy on reproductive system, fertility
10. Recruitment of reproductive features into other cell types may underlie extended lifespan in animals
11. The importance of being helpful -- Cooperative cichlids boost their own reproductive success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... , March 9, 2017 4Dx has ... World Lung Imaging Workshop at the University of Pennsylvania. ... invited to deliver the latest data to world leaders ... event brings together leaders at the forefront of the ... lung imaging. "The quality of the ...
(Date:3/6/2017)... Calif. , March 6, 2017 ... and sales technology, today announced Predictive Sales Coach ... for infusing actionable sales intelligence into Salesforce. This ... automatically enable their sales organizations with deep knowledge ... that allow for intelligent engagement. Predictive Sales Coach ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
Breaking Biology News(10 mins):
(Date:3/20/2017)... ... March 20, 2017 , ... ... interfere with the ability of endogenous hormones to regulate homeostasis via their ... activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological disorders. EDC ...
(Date:3/20/2017)... CA (PRWEB) , ... March 20, 2017 , ... ... require expensive and laborious sample preparation methods in order to reduce the impact ... underappreciated outside of the area of elemental analysis. , This presentation will ...
(Date:3/20/2017)... Clara, CA (PRWEB) , ... March 20, 2017 , ... ... free AFM Demo on Friday, March 24, 2017 from 5-7pm at their ... demo, and a special presentation from imec Senior Researcher, Dr. Tae-Gon Kim. , Dr. ...
(Date:3/20/2017)...  Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating ... or the "Company") (NYSE: BIOA ). Such investors ... by visiting the firm,s site: www.bgandg.com/bioa . ... officers and/or directors have violated Sections 10(b) and 20(a) of ... ...
Breaking Biology Technology: